Results 101 to 110 of about 1,542,035 (213)

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

Surgical Pathology ed.8

, 1999
2021 hal.;ill.; 27 ...
Rosal Juan
core  

Modern surgical pathology

, 2009
Online and in print, Modern Surgical Pathology, 2nd Edition presents today's most complete, current, and practical assistance in evaluating and signing out surgical specimens. Nearly 3,000 high-quality color pathology images provide a crystal-clear basis
Cote, Richard J, Weidner, Noel, Weiss, Lawrence M, Suster, Saul   +3 more
core   +1 more source

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

Molecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad, Silvio Carlo Ermanno Tosatto, Emanuela Leonardi   +2 more
wiley   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial [PDF]

, 2013
Background: Neo-tAnGo, a National Cancer Research Network (NCRN) multicentre randomised neoadjuvant chemotherapy trial in early breast cancer, enroled 831 patients in the United Kingdom.
K Walland, N Fenwick, M Iddawela, E Provenzano, Walland, K., Abraham, J. (Janet), Grier, Anna, L Hiller, J Abraham, A Grier, Fenwick, Nicola, Bowden, S. (Sarah), Iddawela, M., Caldas, C., H M Earl, R Champ, S Bowden, J Dunn, Vallier, A. -L., Champ, R., Earl, Helena M., C Caldas, Dunn, Janet A., Hiller, Louise, A-L Vallier, Provenzano, E.   +25 more
core   +2 more sources

Possibilities of ultrasound in perioperative medicine. A tribute to fashion or the need for clinical search for a surgeon?

Perioperative Medicine, 2019
This article discusses the possibilities of ultrasound in perioperative medicine, namely in the ultrasound study of the superficial organs, lungs, thyroid gland and other internal organs.
Kateryna Dmytriіeva
doaj   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

Molecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso, Md Shohel Ul Islam, Rosa M Xicola, Raj Ramesar, Xavier Llor, Sinclair Steele   +5 more
wiley   +1 more source

Immunohistochemistry of pulmonary biomarkers a perspective from members of the pulmonary pathology society

, 2017
The use of immunohistochemistry for the determination of pulmonary carcinoma biomarkers is a well-established and powerful technique. Immunohistochemisty is readily available in pathology laboratories, is relatively easy to perform and assess, can ...
Rekhtman, Natasha, Hariri, Lida P., Natasha Rekhtman, Sylvie Lantuejoul, Dara L. Aisner, Raparia, Kirtee, Teodora Radonic, Ming Sound Tsao, Capelozzi, Vera L., Aisner, Dara L., Lynette M. Sholl, Izidor Kern, Roy-Chowdhuri, Sinchita, Erik Thunnissen, Vera Luiza Capelozzi, Allen, Timothy C., Prudence Russell, Adam, Julien, Mino-Kenudson, Mari, Wendy Cooper, Mari Mino-Kenudson, Schneider, Frank, Allen, Timothy Craig, Ross Miller, Philip T. Cagle, Julien Adam, Frank Schneider, Cooper, Wendy A. (R14282), Cooper, Wendy, Thunnissen, Erik, Lantuejoul, Sylvie, Yatabe, Yasushi, Tsao, Ming Sound, Lida P. Hariri, Sholl, Lynette M., Yasushi Yatabe, Capelozzi, Vera Luiza, Radonic, Teodora, Sinchita Roy-Chowdhuri, Miller, Ross, Beasley, Mary Beth, Borczuk, Alain C., Kern, Izidor, Mary Beth Beasley, Marina Vivero, Alain C. Borczuk, Cagle, Philip T., Vivero, Marina, Kirtee Raparia, Russell, Prudence, Timothy Craig Allen   +50 more
core   +1 more source

Spatial heterogeneity of hotspot mutations and clonal relatedness in ovarian endometrioid carcinoma

Molecular Oncology, EarlyView.
Spatially resolved analysis revealed heterogeneous distributions of selected cancer‐associated mutations within ovarian endometrioid carcinomas. Shared mutations between paired endometrial and ovarian tumors supported clonal relatedness. These findings highlight the value of sampling multiple tumor regions when interpreting molecular profiles ...
Takahito Ashihara, Kosuke Murakami, Shiro Takamatsu, Akiko Kanto, Seiichi Mori, Tomoyuki Otani, Kazuko Sakai, Yasushi Kotani, Kazuto Nishio, Kaoru Abiko, Noriomi Matsumura   +10 more
wiley   +1 more source